Make therapeutic breakthroughs with bulk immune profiling
Advance Key Therapeutic Areas with Bulk TCR and BCR Sequencing
Discover how our sensitive, quantitative, and high-throughput assay, RepSeq+, provides detailed clonality and diversity insights to drive forward your clinical development and drug discovery programs.
Potential Breakthroughs
Predict treatment efficacy
Profile immune response
Identify biomarkers
Single out neutralizing antibodies
Track CAR-T progression
Therapeutic Areas
Immuno-oncology
Infectious Disease Therapeutics
Autoimmune
BROCHURE
Our services offer:
- Comprehensive TCR and BCR sequencing analysis
- Flexible analysis: DNA or RNA sequencing options
- High-touch, expert support from trial planning to data analysis
